Related references
Note: Only part of the references are listed.Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications
Y. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Emerging evidence of the impact of kidney disease on drug metabolism and transport
T. D. Nolin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The effect of chronic renal failure on drug metabolism and transport
Albert W. Dreisbach et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Effect of Hemodialysis on Hepatic Cytochrome P450 Functional Expression
Josee Michaud et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Downregulation of hepatic acetylation of drugs in chronic renal failure
Emilie Simard et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effects of chronic renal failure on liver drug transporters
Judith Naud et al.
DRUG METABOLISM AND DISPOSITION (2008)
Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites
Miia Turpeinen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Effects of uptake and efflux transporter inhibition on erythromycin breath test results
L. A. Frassetto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Down-regulation of intestinal drug transporters in chronic renal failure in rats
Judith Naud et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis
Sara De Martin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure
Jose Michaud et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Hemodialysis acutely improves hepatic CYP3A4 metabolic activity
Thomas D. Nolin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effects of renal failure on drug transport and metabolism
H Sun et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Effects of uremic toxins on hepatic uptake and metabolism of erythromycin
H Sun et al.
DRUG METABOLISM AND DISPOSITION (2004)
Characterization of hepatic cytochrome P4503A activity in patients with end-stage renal disease
TC Dowling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Cytochrome P4502C9 activity in end-stage renal disease
AW Dreisbach et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Downregulation of intestinal cytochrome P450 in chronic renal failure
FA Leblond et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Unidimensional scale for dementia
H Kashima et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2001)
Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion
C Veau et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Share Paper
